Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reinet Investments S.C.A. is a Luxembourg-based investment holding company that allows its shareholders to participate indirectly in a diversified portfolio of assets. Originally formed in 2008 following the demerger of the luxury goods group Richemont, the company's cornerstone asset is a significant stake in British American Tobacco. Beyond this core holding, Reinet manages a varied portfolio of private equity, specialized funds, and financial services investments, including a major stake in the Pension Insurance Corporation. While the company is primarily an investment vehicle rather than a biotechnology firm, its broad mandate allows it to allocate capital across various global industries. Reinet's investment strategy focuses on long-term capital growth and value creation for its shareholders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reinet Investments.